Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Tommorow is a big day. 5$ will go to ?? 3 or will they let it run with goos news before they start...
– Femasys demonstrates compliance with harmonized regulatory requirements for Australia, Brazil, Japan, Canada and the USA –
– Femasys(FEMY) is committed to bringing innovative solutions to women around the world –
ATLANTA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Femasys Inc.(FEMY) , a biomedical company focused on meeting significant unmet needs for women worldwide with a broad portfolio of in-office, accessible solutions, including a lead late-clinical stage product candidate and innovative diagnostic products, today announced that it has successfully completed the annual Medical Device Single Audit Program (MDSAP) surveillance audit with no non-conformances and no findings.
Femasys (FEMY) currently holds Certificates of Registration for MDSAP from TUV SUD America Inc., a recognized Auditing Organization and Notified Body that conducts a single regulatory audit of medical device manufacturers that satisfies the relevant harmonized regulatory requirements for the countries participating in the MDSAP program, and ISO 13485 Quality System Certification for the commercialization of Femasys(FEMY) products in the U.S., Canada and Japan with the ability to register for market authorization in Australia and Brazil.
“Completion of the MDSAP annual surveillance audit with no non-conformances and no findings demonstrates the robustness of the Femasys Quality System and our continued commitment to compliance that extends to all of our in-house manufacturing capabilities,” said Kathy Lee-Sepsick, founder, president and chief executive officer of Femasys(FEMY). “We look forward to continuing to advance our much-needed innovative technologies in the U.S., as well as other countries around the world, via the MDSAP program."
Femasys (FEMY) is creating accessible innovative options for women, as exemplified by its lead product candidate, FemBloc® in late-stage clinical development for permanent birth control and its now-United States Food and Drug Administration (FDA)-cleared product, FemaSeed® for infertility treatment (also approved in Canada). The Company is commercializing complementary diagnostic products that were internally developed through its in-house manufacturing capabilities, with regulatory approvals in the U.S., Canada and other ex-U.S. territories.
$FEMY
It was too late to change the error ran out of posts
What short Squeeze???? 1% short.!!!
#FEMY 🔥 short squeeze! Nice set up this week! $FEMY
Ask Jesus he would tell you
Thanks........
Z
You might be better off buying MRNJ🤑 lol
Everyone here, spread the word!!! Let’s get this to $5 today
$FEMY Pounding the table here
Great first hour imo
This will see $5 today
Same pattern as pre-market
$FEMY load up folks building momentun
$FEMY glad bought this today. Nice surprise
The bull buck me at 4.50 coming back in the ride bull WOOHOOOOOO WOOHOOOOOO
Somebody trying to stop this play. L2 frozen at 3.66.
Get FEMY over $5 then institutions hedge funds can load up🚀
$FEMY yes bottom in early. Going to be a good week
Same man .. I added low $1 … low to mid $2s and low $3s lol average is 2.32 … I think I may add more at 8 AM. This is still bottom pretty much.
$FEMY I like this one
Nice!! I see $7-$10 this week $5+ today
#DDAmanda Analysis of $FEMY:
Thanks for the numbers
I just don’t see it going that high by Monday …$7 seems very reasonable tho imo
This early $$$$$ most $$$$ can ride freeeeee that’s what I’m doing now :) yeaaaaa
Nearly 160 million traded to day! Something big is brewing folks. Hold on!!
Wooo hoooo!!!
Why not $9 or $10? Sky's the limit with this one.
Followers
|
17
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
411
|
Created
|
07/06/21
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |